Flp-In™-CHO Cell Line - FAQs

在理论上来讲，用户能够实现Flp-In表达载体的多重整合效果——这其中包含了一个FRT-特异性的整合事件和一个随机的第二位点整合事件。不过，随机整合的发生概率相对较低。转染过程中所用DNA的有限数量将减少第二位点的整合概率。我们向293细胞（缺少FRT位点）中转染了pcDNA5/FRT载体，并在筛选了200个以上的克隆后，鉴定到一个潜在的第二整合位点。用户可通过Southern杂交来检测DNA的整合位点。单一整合元件会显示为独立的一个条带；两个整合位点：两个条带；三个位点，三条带，如此延续。我们将一些Flp-In表达细胞系培养了四个月以上，无论是否向培养体系中加入潮霉素，均未发现Flp-In表达载体发生任何形式的丢失。

我们提供向HEK293细胞中稳定整合了pFRT/lacZeo和pcDNA6/TR的Flp-In T-REx系统。该细胞系经功能性测试，能够有效调控目的基因的表达。

In theory, one can get multiple integrations of the Flp-In expression construct—an FRT-specific integration event and a random, second-site integration. However, random integration is a relatively uncommon event. Limiting the amount of DNA in the transfection will reduce the chance of second-site integration. We have transfected 293 cells (lacking the FRT site) with the pcDNA5/FRT vector and have identified one potential second-site integrant after screening over 200 clones. DNA integrations can be detected by Southern blot. A single integrant will display a single band; double: two; triple: three, etc. We have maintained a number of Flp-In expression cell lines for over four months and have not observed any loss of the Flp-In expression construct, whether hygromycin selection was maintained or not.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

We offer the Flp-In T-REx system that contains pFRT/lacZeo and pcDNA6/TR stably integrated into HEK 293 cells. This cell line has been functionally tested for its ability to regulate expression.